Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo | Synapse
March 3, 2026Open Access
Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo
Key Points
3D imaging offers an objective way to assess changes in facial vitiligo after treatment.
The trial indicates potential benefits from upadacitinib for patients with this skin condition.
Randomized controlled trial methods were applied to ensure reliable results with treatment evaluation.
Results suggest that using 3D imaging could refine monitoring in vitiligo therapies.
Abstract
3D imaging shows potential as an objective tool for evaluating changes in facial vitiligo after UPA treatment.